Abstract
The putative existence of a cancer stem cell niche consisting of bi-directional stromal and stem cell secreting factors that trigger cancer stem cell growth and proliferation has been hypothesized in the nervous and hematopoietic systems. In light of this theory, it has been proposed that embryonic stem cell microenvironments, upon interactions with cancer stem cells, may reprogram cancer cells resulting in a substantial inhibition of tumor cell properties. Here, we discuss emerging data that support this novel concept of cancer inhibitory factors produced in the context of embryonic microenvironments as well as by embryonic stem cells (ESCs).
Similar content being viewed by others
References
Fuchs, E., Tumbar, T., & Guasch, G. (2004). Socializing with the neighbors: stem cells and their niche. Cell, 116(6), 769–778.
Morrison, S. J., & Spradling, A. C. (2008). Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell, 132(4), 598–611.
Rideout, W. M., 3rd, Hochedlinger, K., Kyba, M., Daley, G. Q., & Jaenisch, R. (2002). Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell, 109(1), 17–27.
Wernig, M., Meissner, A., Foreman, R., Brambrink, T., Ku, M., Hochedlinger, K., et al. (2007). In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature, 448(7151), 318–324.
Aleckovic, M., & Simón, C. (2008). Is teratoma formation in stem cell research a characterization tool or a window to developmental biology? Reproductive Biomedicine Online, 17(2), 270–280.
Hanna, J., Markoulaki, S., Mitalipova, M., Cheng, A. W., Cassady, J. P., Staerk, J., et al. (2009). Metastable pluripotent states in NOD-mouse-derived ESCs. Cell Stem Cell, 4(6), 513–524.
Blum, B., & Benvenisty, N. (2008). The tumorigenicity of human embryonic stem cells. Advances in Cancer Research, 100, 133–158.
Watt, F. M., & Hogan, B. L. (2000). Out of Eden: stem cells and their niches. Science, 287(5457), 1427–1430.
Morrison, S. J., & Spradling, A. C. (2008). Stem cells and niches: mechanisms that promote stem cell maintenance throughout life. Cell, 132(4), 598–611.
Oshima, H., Rochat, A., Kedzia, C., Kobayashi, K., & Barrandon, Y. (2001). Morphogenesis and renewal of hair follicles from adult multipotent stem cells. Cell, 104(2), 233–245.
Taylor, G., Lehrer, M. S., Jensen, P. J., Sun, T. T., & Lavker, R. M. (2000). Involvement of follicular stem cells in forming not only the follicle but also the epidermis. Cell, 102(4), 451–461.
Tumbar, T., Guasch, G., Greco, V., Blanpain, C., Lowry, W. E., Rendl, M., et al. (2004). Defining the epithelial stem cell niche in skin. Science, 303(5656), 359–363.
Chen, D., & McKearin, D. (2003). Dpp signaling silences bam transcription directly to establish asymmetric divisions of germline stem cells. Current Biology, 13(20), 1786–1791.
Zhao, G. Q., Deng, K., Labosky, P. A., Liaw, L., & Hogan, B. L. (1996). The gene encoding bone morphogenetic protein 8B is required for the initiation and maintenance of spermatogenesis in the mouse. Genes and Development, 10(13), 1657–1669.
Brown, S., Zeidler, M. P., & Hombría, J. E. (2006). JAK/STAT signalling in Drosophila controls cell motility during germ cell migration. Developmental Dynamics, 235(4), 958–966.
Matsuda, T., Nakamura, T., Nakao, K., Arai, T., Katsuki, M., Heike, T., et al. (1999). STAT3 activation is sufficient to maintain an undifferentiated state of mouse embryonic stem cells. EMBO Journal, 18(15), 4261–4269.
Gat, U., DasGupta, R., Degenstein, L., & Fuchs, E. (1998). De Novo hair follicle morphogenesis and hair tumors in mice expressing a truncated beta-catenin in skin. Cell, 95(5), 605–614.
Song, X., & Xie, T. (2003). Wingless signaling regulates the maintenance of ovarian somatic stem cells in Drosophila. Development, 130(14), 3259–3268.
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., et al. (2002). The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell, 111(2), 241–250.
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., et al. (2003). A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 423(6938), 409–414.
Virchow, R. L. K. (1858). Cellular Pathology. A. Hirschwald (Ed.).Berlin.
Sell, S. (2004). Stem cell origin of cancer and differentiation therapy. Critical Reviews in Oncology/hematology, 51(1), 1–28.
Garraway, L. A., & Sellers, W. R. (2006). Lineage dependency and lineage-survival oncogenes in human cancer. Nature Reviews Cancer, 6(8), 593–602.
Yang, Z. J., & Wechsler-Reya, R. J. (2007). Hit ’em where they live: targeting the cancer stem cell niche. Cancer Cell, 11(1), 3–5.
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., et al. (1994). A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature, 367(6464), 645–648.
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H., Jones, D. L., et al. (2006). Cancer stem cells–perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Research, 66(19), 9339–9344.
Ginestier, C., Hur, M. H., Charafe-Jauffret, E., Monville, F., Dutcher, J., Brown, M., et al. (2007). ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell, 1(5), 555–567.
Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine, 3(7), 730–737.
Singh, S. K., Clarke, I. D., Terasaki, M., Bonn, V. E., Hawkins, C., Squire, J., et al. (2003). Identification of a cancer stem cell in human brain tumors. Cancer Research, 63(18), 5821–5828.
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003). Prospective identification of tumorigenic breast cancer cells. Proceedings of the National Academy of Sciences USA, 100(7), 3983–3988.
O’Brien, C. A., Pollett, A., Gallinger, S., & Dick, J. E. (2007). A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature, 445(7123), 106–110.
Zhang, S., Balch, C., Chan, M. W., Lai, H. C., Matei, D., Schilder, J. M., et al. (2008). Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Research, 68(11), 4311–4320.
Guo, W., Lasky, J. L., Chang, C. J., Mosessian, S., Lewis, X., Xiao, Y., et al. (2008). Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation. Nature, 453(7194), 529–533.
Singh, S. K., Hawkins, C., Clarke, I. D., Squire, J. A., Bayani, J., Hide, T., et al. (2004). Identification of human brain tumour initiating cells. Nature, 432(7015), 396–401.
Cho, R. W., & Clarke, M. F. (2008). Recent advances in cancer stem cells. Current Opinion in Genetics and Development, 18(1), 48–53.
Zhang, M., Behbod, F., Atkinson, R. L., Landis, M. D., Kittrell, F., Edwards, D., et al. (2008). Identification of tumor-initiating cells in a p53-null mouse model of breast cancer. Cancer Research, 68(12), 4674–4682.
Huntly, B. J., Shigematsu, H., Deguchi, K., Lee, B. H., Mizuno, S., Duclos, N., et al. (2004). MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell, 6(6), 587–596.
Postovit, L. M., Seftor, E. A., Seftor, R. E., & Hendrix, M. J. (2006). Influence of the microenvironment on melanoma cell fate determination and phenotype. Cancer Research, 66(16), 7833–7836.
Bissell, M. J., & Radisky, D. (2001). Putting tumours in context. Nature Reviews Cancer, 1(1), 46–54.
Gupta, G. P., & Massagué, J. (2006). Cancer metastasis: building a framework. Cell, 127(4), 679–695.
Hanahan, D., & Weinberg, R. A. (2000). The hallmarks of cancer. Cell, 100(1), 57–70.
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002). Dissemination and growth of cancer cells in metastatic sites. Nature Reviews Cancer, 2(8), 563–572.
Huang, J., Frischer, J. S., Serur, A., Kadenhe, A., Yokoi, A., McCrudden, K. W., et al. (2003). Regression of established tumors and metastases by potent vascular endothelial growth factor blockade. Proceedings of the National Academy of Sciences USA, 100(13), 7785–7790.
Pardal, R., Clarke, M. F., & Morrison, S. J. (2003). Applying the principles of stem-cell biology to cancer. Nature Reviews Cancer, 3(12), 895–902.
Bonnet, D., & Dick, J. E. (1997). Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nature Medicine, 3(7), 730–737.
Lessard, J., & Sauvageau, G. (2003). Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature, 423(6937), 255–260.
Bissell, M. J., & Labarge, M. A. (2005). Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment? Cancer Cell, 7(1), 17–23.
Mantovani, A. (2005). Cancer: inflammation by remote control. Nature, 435(7043), 752–753.
Rosen, J. M., & Jordan, C. T. (2009). The increasing complexity of the cancer stem cell paradigm. Science, 324(5935), 1670–1673.
Calabrese, C., Poppleton, H., Kocak, M., Hogg, T. L., Fuller, C., Hamner, B., et al. (2007). A perivascular niche for brain tumor stem cells. Cancer Cell, 11(1), 69–82.
Tlsty, T. D., & Coussens, L. M. (2006). Tumor stroma and regulation of cancer development. Annual Review of Pathol, 1, 119–150.
Walkley, C. R., Olsen, G. H., Dworkin, S., Fabb, S. A., Swann, J., McArthur, G. A., et al. (2007). A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. Cell, 129(6), 1097–1110.
Walkley, C. R., Shea, J. M., Sims, N. A., Purton, L. E., & Orkin, S. H. (2007). Rb regulates interactions between hematopoietic stem cells and their bone marrow microenvironment. Cell, 129(6), 1081–1095.
Bao, S., Wu, Q., Sathornsumetee, S., Hao, Y., Li, Z., Hjelmeland, A. B., et al. (2006). Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor. Cancer Research, 66(16), 7843–7848.
Kaplan, R. N., Riba, R. D., Zacharoulis, S., Bramley, A. H., Vincent, L., Costa, C., et al. (2005). VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature, 438(7069), 820–827.
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., et al. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145–1147.
Draper, J. S., Moore, H. D., Ruban, L. N., Gokhale, P. J., & Andrews, P. W. (2004). Culture and characterization of human embryonic stem cells. Stem Cells and Development, 13(4), 325–336.
Rao, M. (2004). Conserved and divergent paths that regulate self-renewal in mouse and human embryonic stem cells. Developmental Biology, 275(2), 269–286.
Surani, M. A., Hayashi, K., & Hajkova, P. (2007). Genetic and epigenetic regulators of pluripotency. Cell, 128(4), 747–762.
Calvanese, V., Horrillo, A., Hmadcha, A., Suarez-Alvarez, B., Fernandez, A. F., Lara, E., et al. (2008). Cancer genes hypermethylated in human embryonic stem cells. PLoS ONE, 3(9), e3294.
Jaenisch, R., & Young, R. (2008). Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell, 132(4), 567–582.
Draper, J. S., Smith, K., Gokhale, P., Moore, H. D., Maltby, E., Johnson, J., et al. (2004). Recurrent gain of chromosomes 17q and 12 in cultured human embryonic stem cells. Nature Biotechnology, 22(1), 53–54.
Vanneste, E., Voet, T., Le Caignec, C., Ampe, M., Konings, P., Melotte, C., et al. (2009). Chromosome instability is common in human cleavage-stage embryos. Nature Medicine, 15(5), 577–583.
Pierce, G. B., Pantazis, C. G., Caldwell, J. E., & Wells, R. S. (1982). Specificity of the control of tumor formation by the blastocyst. Cancer Research, 42(3), 1082–1087.
Cucina, A., Biava, P. M., D’Anselmi, F., Coluccia, P., Conti, F., di Clemente, R., et al. (2006). Zebrafish embryo proteins induce apoptosis in human colon cancer cells (Caco2). Apoptosis, 11(9), 1617–1628.
Postovit, L. M., Margaryan, N. V., Seftor, E. A., Kirschmann, D. A., Lipavsky, A., Wheaton, W. W., et al. (2008). Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells. Proceedings of the National Academy of Sciences USA, 105(11), 4329–4334.
Topczewska, J. M., Postovit, L. M., Margaryan, N. V., Sam, A., Hess, A. R., Wheaton, W. W., et al. (2006). Embryonic and tumorigenic pathways converge via Nodal signaling: role in melanoma aggressiveness. Nature Medicine, 12(8), 925–932.
Dürr, M., Harder, F., Merkel, A., Bug, G., Henschler, R., & Müller, A. M. (2003). Chimaerism and erythroid marker expression after microinjection of human acute myeloid leukaemia cells into murine blastocysts. Oncogene, 22(57), 9185–9191.
Mintz, B., & Illmensee, K. (1975). Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proceedings of the National Academy of Sciences USA, 72(9), 3585–3589.
Gerschenson, M., Graves, K., Carson, S. D., Wells, R. S., & Pierce, G. B. (1986). Regulation of melanoma by the embryonic skin. Proceedings of the National Academy of Sciences USA, 83(19), 7307–7310.
Dolberg, D. S., & Bissell, M. J. (1984). Inability of Rous sarcoma virus to cause sarcomas in the avian embryo. Nature, 309(5968), 552–556.
Okita, K., Ichisaka, T., & Yamanaka, S. (2007). Generation of germline-competent induced pluripotent stem cells. Nature, 448(7151), 313–317.
Hendrix, M. J., Seftor, E. A., Seftor, R. E., Kasemeier-Kulesa, J., Kulesa, P. M., & Postovit, L. M. (2007). Reprogramming metastatic tumour cells with embryonic microenvironments. Nature Reviews Cancer, 7(4), 246–255.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ruiz-Vela, A., Aguilar-Gallardo, C. & Simón, C. Building a Framework for Embryonic Microenvironments and Cancer Stem Cells. Stem Cell Rev and Rep 5, 319–327 (2009). https://doi.org/10.1007/s12015-009-9096-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12015-009-9096-7